Baclofen for anxiety disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Dec 2012: Trial registered, NCT01751386
  2. 17 Aug 2016: Trial completed, NCT01751386

The trials

NCT01751386: Baclofen for Treating Anxiety and Alcoholism

State
Completed
Phase
Phase 2
People
39 taking part
Started
3 Dec 2012
Primary completion
17 Aug 2016
Arms
Baclofen
Results
Posted on the registry
  1. 18 Dec 2012: Trial registered
  2. 17 Aug 2016: Trial completed
  3. 16 Aug 2017: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Baclofen 30mg, Baclofen 30mg/day, Baclofen 60mg, Baclofen 75mg/day, Fleqsuvy, Gablofen, Kemstro, Lioresal, Lyvispah, Ozobax.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.